title: Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013.
abstract: As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin-peginterferon-α therapy.
authors.forename: Asim
authors.initials: A
authors.lastname: Malik
authors.forename: Karim Medhat
authors.initials: KM
authors.lastname: El Masry
authors.forename: Mini
authors.initials: M
authors.lastname: Ravi
authors.forename: Falak
authors.initials: F
authors.lastname: Sayed
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D018352:Coronavirus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000266:history / Q000821:virology*; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D049674:History, 21st Century; D006801:Humans; D065207:Middle East Respiratory Syndrome Coronavirus / Q000145:classification / Q000235:genetics; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000266:history / Q000821:virology*; D014479:United Arab Emirates / Q000453:epidemiology
chemical_list: D000998:Antiviral Agents
keywords: Abu Dhabi; MERS-CoV; Middle East respiratory syndrome coronavirus; UAE; United Arab Emirates; WHO; World Health Organization; fatal outcome; influenza-like illness; pregnancy; surveillance; treatment; viruses